引用本文:柯立晖,李 辉.血细胞计数及功能与肿瘤患者静脉血栓栓塞症相关性研究进展[J].中国临床新医学,2022,15(4):292-297.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 199次   下载 435 本文二维码信息
码上扫一扫!
分享到: 微信 更多
血细胞计数及功能与肿瘤患者静脉血栓栓塞症相关性研究进展
柯立晖,李 辉
100020 北京,首都医科大学附属北京朝阳医院胸外科
摘要:
[摘要] 静脉血栓栓塞症(VTE)是肿瘤患者常见的并发症,严重影响患者预后与生存,VTE的发生发展受多种因素影响。肿瘤进展及肿瘤治疗会影响患者血液系统中众多血细胞计数及功能,后者变化在肿瘤进展、促进血液高凝状态及血栓形成方面发挥着重要的作用。除了针对凝血因子的抗凝药物外,针对血细胞相应靶点的药物可能成为未来预防及治疗VTE的新途径。为此,该文就血细胞计数及功能变化与肿瘤相关VTE的研究进展作一综述。
关键词:  静脉血栓栓塞症  肿瘤  血细胞计数  生物标志物
DOI:10.3969/j.issn.1674-3806.2022.04.03
分类号:R 730.6
基金项目:
Research progress in the correlation of blood cell count and function with venous thromboembolism in tumor patients
KE Li-hui, LI Hui
Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
Abstract:
[Abstract] Venous thromboembolism(VTE) is a common complication in tumor patients, which seriously affects the prognosis and survival of the patients. The occurrence and development of VTE is influenced by many factors. Tumor progression and tumor treatment affect the count and function of numerous blood cells in the patients′ blood system, and the changes of the latter play an important role in tumor progression, promoting blood hypercoagulability and thrombosis. In addition to anticoagulant drugs targeting coagulation factors, drugs targeting corresponding targets of blood cells may become new approaches of VTE prevention and treatment in the future. Therefore, this paper reviews the research progress in blood cell count and functional changes, and tumor-associated VTE.
Key words:  Venous thromboembolism(VTE)  Tumor  Blood cell count  Biomarker